Wallace 1991.
Methods | RCT Accrual 1984‐1988 | |
Participants | 159 T2‐T4, Nx, M0 | |
Interventions | Radiotherapy alone vs. Neoadjuvant chemotherapy + radiotherapy Neoadjuvant CT: 3 cycles every3 weeks of Cisplatin (100mg/m2) |
|
Outcomes | Survival | |
Notes | Single‐agent cisplatin | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Low risk | A ‐ Adequate |